Cargando…
Aging Affects the Efficacy of Platelet-Rich Plasma Treatment for Osteoarthritis
Despite the increased use of platelet-rich plasma in the treatment of osteoarthritis, whether and how age of the platelet-rich plasma donor affects therapeutic efficacy is unclear. DESIGN: In vitro, male osteoarthritic human chondrocytes were treated with platelet-rich plasma from young (18–35 yrs)...
Autores principales: | Chowdhary, Kuntal, Sahu, Amrita, Iijima, Hirotaka, Shinde, Sunita, Borg-Stein, Joanne, Ambrosio, Fabrisia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245083/ https://www.ncbi.nlm.nih.gov/pubmed/36480365 http://dx.doi.org/10.1097/PHM.0000000000002161 |
Ejemplares similares
-
The immature platelet fraction affects the efficacy of platelet rich plasma therapy for knee osteoarthritis
por: Uchino, Sayuri, et al.
Publicado: (2021) -
Factors affecting the features of platelet-rich plasma in patients with knee osteoarthritis
por: Karaborklu Argut, Sezen, et al.
Publicado: (2023) -
Caspase1/11 signaling affects muscle regeneration and recovery following ischemia, and can be modulated by chloroquine
por: Sachdev, Ulka, et al.
Publicado: (2020) -
Advantages of Pure Platelet-Rich Plasma Compared with Leukocyte- and Platelet-Rich Plasma in Treating Rabbit Knee Osteoarthritis
por: Yin, Wen-Jing, et al.
Publicado: (2016) -
Combination of Platelet-Rich Plasma and Hyaluronic Acid vs. Platelet-Rich Plasma Alone for Treatment of Knee Osteoarthritis
por: Gupta, Ashim, et al.
Publicado: (2023)